Clinical Trial Update: AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients [Phase 3]

View source ↗

Summary

This document reports Phase 3 results evaluating the safety and efficacy of apixaban in Japanese patients with acute deep vein thrombosis or pulmonary embolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Pfizer | Conditions: Deep Vein Thrombosis, Pulmonary Embolism | Phase 3 | Status: COMPLETED | Results posted: 2016-06-23